We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule (49293)

ARTG ID 49293

ARTG Name

Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule

Product name

Bridgewest LIDOCAINE INJECTION 2% 100 mg/5 mL solution for injection ampoule

ARTG Date

22 June 1994

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

lidocaine hydrochloride monohydrate

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

Pfizer (Australia) LIGNOCAINE HYDROCHLORIDE 2% (100 mg/5 mL) injection BP ampoule, Bridgewest Perth Pharma Pty Ltd, CON-1135

24 July 2023

Section 14 consent

Consent to supply while noncompliant with standards. The consent is effective from 24 July 2023 until 31 July 2025.
Pfizer (Australia) LIGNOCAINE HYDROCHLORIDE 2% (100 mg/5 mL) injection BP ampoule, Pfizer Australia Pty Ltd, CON-1029

1 November 2022

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 1 November 2022 until 1 November 2023.